MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Omega Diagnostics welcomes positive Covid testing data alongside vaccine use

StockMarketWire.com

Disease test-kit supplier Omega Diagnostics welcomed the publication of data that showed Covid-19 tests were effective when used in conjunction with the Pfizer-BioNTeach vaccine.

The UK Rapid Test Consortium, of which Omega was a partner, had presented new data relating to the performance of the AbC-19TM rapid antibody test.

'The initial study performed at the University of Birmingham highlighted the effectiveness of the AbC-19TM rapid antibody test in demonstrating immune response following vaccination,' the company said.

In total 193 individuals who had received a COVID-19 vaccine were tested for the presence of IgG antibodies to the full trimeric spike using the AbC-19TM test.

Of those individuals, a sub-set of 65 patients had been determined to have previously been infected with COVID-19, and 128 had no previous infection.

The study also concluded that patients previously infected with Covid-19 showed a stronger immune response to the first dose of the Pfizer-BioNTech Covid-19 vaccine.



Story provided by StockMarketWire.com